Tags: Celltrionsubcutaneous infliximabinflammatory bowel disease
| Profile | Contacts | Recent Articles on Subject | |
|---|---|---|---|
| 1 | John Pinching PharmaTimes Next-gen biopharma company. La Jolla, California | Scottish medicines consortium approves CAR T-cell therapy for blood cancer - about 1 month ago Poolbeg’s cytokine release syndrome drug shows potential - 11 months ago | |
| 2 | Adam Feuerstein STAT News Reporter at STATnews. Dog lover. Polk Award winner. Boston, Massachusetts | STAT+: Early data from Arcellx, Gilead suggest CAR-T for multiple myeloma could offer safety benefit - about 2 months ago | |
| 3 | Jonathan Wosen STAT News West Coast Biotech Reporter. Formerly @sdut. Stanford PhD. UCSC alum. San Diego, California | ||
| 4 | Ian Ingram MedPage Today Deputy Managing Editor.
MedPage Today. New York, New York | FDA Approves Earlier Use of CAR-T Products for Myeloma - 9 months ago FDA Approves First CAR-T for Chronic Lymphocytic Leukemia - 9 months ago JAK1 Inhibitor Shows 'Remarkable' Activity in T-Cell Lymphoma - about 1 year ago Menin Inhibitor Yields 63% ORR in Heavily Pretreated Acute Leukemia - about 1 year ago Frontline Venetoclax-Ibrutinib for CLL Boosts Survival in Fit Patients - about 1 year ago Non-Covalent BTK Inhibitor Approved for CLL - about 1 year ago | |
| 5 | Frank Vinluan MedCity News Medical innovation tracker. MedCity, USA | ||
| 6 | Mike Bassett MedPage Today Explains healthcare complexities. Not endorsements. New York, New York | Oncolytic Virus Shows High Response Rates in BCG-Unresponsive Bladder Cancer - about 1 year ago | |
| 7 | Judy George MedPage Today Medical reporter, writer. | ||
| 8 | Meagan Parrish Pharma Voice Senior editor @industrydive.
Pharma world follower. Wisconsin, USA | ||
| 9 | Alana Hippensteele, Managing Editor Pharmacy Times #pharmacy news, insights. CE provider. Cranbury, New Jersey | FDA Approves Axatilimab-csfr for cGVHD - 4 months ago | |
| 10 | Andrew Joseph STAT News Reporter at STAT. Covers health, medicine in Europe. London, England |